MedTrace Logo

Longitudinal Registry Including Patients Treated With Heavy Particles

NCT05203250 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2025-08-06

No results posted yet for this study

Summary

The purpose of this registry is to collect retrospective and prospective standardized data of patients treated with particle therapy, either with protons or carbon ions, at the National Center for Oncological Hadrontherapy (CNAO) based in Pavia.

By keeping track of the patients treated, it will allow the investigators to periodically analyze and evaluate data collected of daily clinical activity. This will help gathering more information on the results of particle therapy and will provide the basis for in depth evaluation of patients' outcome with respect to the delivered treatment.

Conditions

Interventions

RADIATION

Heavy-ion therapy (hadrontherapy)

Only data available from routine clinical practice at the National Center for Oncological Hadrontherapy (CNAO), based Pavia, will be collected. Intervention is not assigned.

Sponsors & Collaborators

  • CNAO National Center of Oncological Hadrontherapy

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-04
Primary Completion
2030-06-04
Completion
2071-06-04

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05203250 on ClinicalTrials.gov